The accordant variations between MIB2 and cyclins confirm the promoting role of MIB2 in lung cancer cells and remind us that MIB2 may activate the progression of lung cancer through promoting the accumulation of cell cycle complexes. Here, MIB2 is linked to lung carcinoma.